Application 022044
- Type
- NDA
- Sponsor
- MERCK SHARP DOHME
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | TABLET;ORAL | 500MG;EQ 50MG BASE | Yes | No |
| 002 | JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | TABLET;ORAL | 1GM;EQ 50MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022044-001 | JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 500MG;EQ 50MG BASE | TABLET / ORAL | AB | RLD | 2007-03-30 |
| N022044-002 | JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 50MG BASE | TABLET / ORAL | AB | RLD, RS | 2007-03-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022044-001 | AB |
| N022044-002 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022044-001 | 7326708 | 2026-11-24 | U-802 | Drug substance, Drug product | |
| N022044-001 | 7326708*PED | 2027-05-24 | Pediatric extension | ||
| N022044-001 | 8414921 | 2028-07-21 | U-1036 | Drug product | 2013-04-09 |
| N022044-001 | 8414921*PED | 2029-01-21 | Pediatric extension | ||
| N022044-002 | 7326708 | 2026-11-24 | U-802 | Drug substance, Drug product | |
| N022044-002 | 7326708*PED | 2027-05-24 | Pediatric extension | ||
| N022044-002 | 8414921 | 2028-07-21 | U-1036 | Drug product | |
| N022044-002 | 8414921*PED | 2029-01-21 | Pediatric extension |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022044-001 | JANUMET | 500MG;EQ 50MG BASE | TABLET / ORAL | AB | RLD | 2007-03-30 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N022044-002 | JANUMET | 1GM;EQ 50MG BASE | TABLET / ORAL | AB | RLD, RS | 2007-03-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022044-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N022044-002 | AB | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022044-001 | 7326708 | 2026-11-24 | U-802 | Drug substance, Drug product | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022044-001 | 7326708*PED | 2027-05-24 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N022044-001 | 8414921 | 2028-07-21 | U-1036 | Drug product | 2013-04-09 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N022044-001 | 8414921*PED | 2029-01-21 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N022044-002 | 7326708 | 2026-11-24 | U-802 | Drug substance, Drug product | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022044-002 | 7326708*PED | 2027-05-24 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N022044-002 | 8414921 | 2028-07-21 | U-1036 | Drug product | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022044-002 | 8414921*PED | 2029-01-21 | Pediatric extension | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | c603b844-2019-4ef4-8385-7bc3f96a2565 | 2026-07-13 | Boxed warning, Warnings, Adverse reactions | 022044 NDA022044 |
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b55ee3d9-7f0b-4dd9-9213-fbc69f09f567 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 022044 NDA022044 |
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | d19c7ed0-ad5c-426e-b2df-722508f97d67 | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | 022044 NDA022044 0006-0575 0006-0577 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0575 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0577 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme Corp. | NDA | Current |
| 50090-5618 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | A-S Medication Solutions | NDA | Current |
| 70518-2548 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | NDA | Current |
| 70518-2548 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | NDA | Current |
| 70518-2548 | JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71440 | SUPPL | 2022-06-24 |
| 71439 | SUPPL | 2022-06-24 |
| 71426 | SUPPL | 2022-06-22 |
| 69428 | SUPPL | 2021-12-01 |
| 69261 | SUPPL | 2021-11-05 |
| 65547 | SUPPL | 2020-12-09 |
| 65521 | SUPPL | 2020-12-08 |
| 65502 | SUPPL | 2020-12-04 |
| 59689 | SUPPL | 2019-08-13 |
| 59688 | SUPPL | 2019-08-13 |
| 59683 | SUPPL | 2019-08-13 |
| 59281 | SUPPL | 2019-07-09 |
| 59280 | SUPPL | 2019-07-09 |
| 59208 | SUPPL | 2019-07-02 |
| 52634 | SUPPL | 2018-02-14 |
| 52559 | SUPPL | 2018-02-12 |
| 52555 | SUPPL | 2018-02-12 |
| 49406 | SUPPL | 2017-08-15 |
| 49350 | SUPPL | 2017-08-14 |
| 46944 | SUPPL | 2017-01-24 |
| 46943 | SUPPL | 2017-01-24 |
| 46923 | SUPPL | 2017-01-18 |
| 46922 | SUPPL | 2017-01-18 |
| 38134 | SUPPL | 2015-09-04 |
| 29138 | SUPPL | 2015-09-01 |
| 38133 | SUPPL | 2015-05-04 |
| 29137 | SUPPL | 2015-04-29 |
| 29136 | SUPPL | 2013-09-24 |
| 38132 | SUPPL | 2013-09-17 |
| 44168 | ORIG | 2013-04-29 |
| 38131 | SUPPL | 2013-02-08 |
| 29135 | SUPPL | 2013-02-08 |
| 16828 | SUPPL | 2012-10-22 |
| 6757 | SUPPL | 2012-10-22 |
| 29134 | SUPPL | 2012-03-27 |
| 16827 | SUPPL | 2012-03-27 |
| 6753 | SUPPL | 2011-06-17 |
| 16825 | SUPPL | 2011-05-16 |
| 6754 | SUPPL | 2011-05-16 |
| 6755 | SUPPL | 2011-04-19 |
| 16824 | SUPPL | 2011-04-18 |
| 38130 | SUPPL | 2010-09-29 |
| 29133 | SUPPL | 2010-09-29 |
| 16826 | SUPPL | 2010-09-29 |
| 6756 | SUPPL | 2010-09-29 |
| 29132 | SUPPL | 2010-03-04 |
| 6752 | SUPPL | 2010-03-04 |
| 6750 | SUPPL | 2010-03-04 |
| 38129 | SUPPL | 2010-03-02 |
| 16823 | SUPPL | 2010-03-02 |
| 16822 | SUPPL | 2010-03-02 |
| 6751 | SUPPL | 2010-01-14 |
| 38128 | SUPPL | 2009-12-31 |
| 29131 | SUPPL | 2008-10-23 |
| 21916 | ORIG | 2008-07-08 |
| 6749 | SUPPL | 2008-05-07 |
| 29129 | SUPPL | 2008-02-29 |
| 6747 | SUPPL | 2008-02-29 |
| 38126 | SUPPL | 2008-02-28 |
| 38125 | SUPPL | 2008-02-28 |
| 29130 | SUPPL | 2008-01-09 |
| 6748 | SUPPL | 2008-01-09 |
| 6746 | SUPPL | 2008-01-09 |
| 38127 | SUPPL | 2008-01-08 |
| 16821 | SUPPL | 2008-01-08 |
| 16820 | SUPPL | 2008-01-08 |
| 29128 | ORIG | 2007-04-09 |
| 16819 | ORIG | 2007-04-06 |